Biotech startups that raised a seed round in China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Tushen Zhihe | Minhang | Seed | $1.4M | 2026-11-09 |
| Magicpen Bio | Hefei | Seed | $1.4M | 2026-02-06 |
| Micro-Ray Technology | Suzhou | Seed | $14.4M | 2026-01-23 |
| Essentia Biosciences | Haidian | Seed | $14.3M | 2026-01-01 |
| Levinthal | Hangzhou | Seed | $1K | 2025-12-09 |
| Phrontline Biopharma | Shanghai | Seed | $60.0M | 2025-11-21 |
| Hangzhou Weiyuan Biotechnology | Hangzhou | Seed | $13.9M | 2025-08-19 |
| Aptech | Hangzhou | Seed | $1.4M | 2025-01-02 |
8 rows of the CSV in 5 of its 18 columns.
- The 419 biotech startups in China whose last round is a seed round have raised $1.5B in total.
- 84 of them closed their most recent round in the last 12 months, $471.4M combined.
- The largest of those rounds is Active Technology's $69.4M angel round, dated November 2026.
- The most recent is Tushen Zhihe's $1.4M seed round on 9 November 2026.
- Kaitai Capital is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 336 companies (80%).
- 57% were founded in 2020 or later; the median founding year is 2020.
- The most common team size is 11 to 50 employees (57% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
14 of 419| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Tushen Zhihe | Tushen Zhihe provides artificial intelligence protein design services. | Artificial intelligence | Minhang | Seed | $1.4M | 2026-11-09 | $1.5M | Wuxi Capital, CHENGMEI VENTURES | 11 to 50 | 2023 |
| Magicpen Bio | Magicpen Bio produces and sells crop seeds and conducts agricultural research. | Biotech | Hefei | Seed | $1.4M | 2026-02-06 | $1.4M | Plum Ventures | 2023 | |
| Micro-Ray Technology | Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. | Biotech | Suzhou | Seed | $14.4M | 2026-01-23 | $14.4M | Suzhou Xiangcheng Financial Holding Group | 11 to 50 | 2021 |
| Essentia Biosciences | Essentia Biosciences develops cell therapies, gene technology drugs, and medical devices. | Biotech | Haidian | Seed | $14.3M | 2026-01-01 | $14.3M | BioVenture, Haitang Fund, Beijing Molecular Technology | 1 to 10 | 2021 |
| Levinthal | Levinthal uses artificial intelligence for protein design and co-evolution in food safety and medical care. | Artificial intelligence | Hangzhou | Seed | $1K | 2025-12-09 | $1.6M | ZhenFund, Kaitai Capital, Pan-Lin Capital +1 | 1 to 10 | 2021 |
| Phrontline Biopharma | Phrontline Biopharma develops antibody-drug conjugate products to treat cancer. | Biotech | Shanghai | Seed | $60.0M | 2025-11-21 | $73.8M | Decheng Capital, Med-Fine Capital | 11 to 50 | 2022 |
| Mckenwei Technology | Mckenwei Technology provides synthetic biology manufacturing services for biochemical engineering. | Biotech | Changshan | Angel | $1.4M | 2024-11-12 | Changcai Private Equity Fund Company | 11 to 50 | 2023 | |
| Shenji Changhua | Shenji Changhua is a biotechnology company focused on neurological diseases such as ALS. | Biotech | Changping | Seed | $13.8M | 2024-08-01 | $16.5M | Tsinghua Capital, MSA Capital, Zhongbo Juli | 11 to 50 | 2021 |
| Meiyou Technology | Meiyou Technology develops DNA synthesizers using enzymatic technology for long-fragment DNA synthesis and splicing. | Biotech | Shanghai | Angel | $1.4M | 2024-06-28 | MiraclePlus, Linear Capital, Danen Capital | 11 to 50 | 2023 | |
| Taiyi Guanjia | Taiyi Guanjia operates a medical service platform that uses family doctors to connect technology with healthcare. | Biotech | Xuhui | Seed | $127.3M | 2024-05-08 | $127.3M | Mitsui Sumitomo Insurance Company | 251 to 500 | 2020 |
| Enzymecode Biotechnology | Enzymecode develops and produces brain health nutritional raw materials and food ingredients. | Biotech | Tianjin | Angel | $1.4M | 2023-12-29 | Draper Dragon | 11 to 50 | 2017 | |
| Wisbiom | Wisbiom develops microecological preparations and microbiome-related products. | Biotech | Changping | Seed | $1.4M | 2023-12-18 | $1.4M | Hengxu Capital, ELIM Capital | 2017 | |
| Ibiome Biology | Ibiome Biology develops intestinal bacteria drugs, focusing on microorganism and metabolite pharmaceuticals. | Biotech | Hefei | Seed | $13.9M | 2023-11-20 | CICC Capital | 51 to 100 | 2021 | |
| JOYCUS | JOYCUS runs an online education platform for children. | Biotech | Shunyi | Angel | $473K | 2018-01-29 | Cyanhill Capital | 11 to 50 | 2015 |
Table 1. Biotech startups that raised a seed round in China: the 14 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 419.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Phrontline Biopharma | Phrontline Biopharma develops antibody-drug conjugate products to treat cancer. | Biotech | Shanghai | Seed | $60.0M | 2025-11-21 | $73.8M | Decheng Capital, Med-Fine Capital | 11 to 50 | 2022 |
| 2 | Micro-Ray Technology | Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. | Biotech | Suzhou | Seed | $14.4M | 2026-01-23 | $14.4M | Suzhou Xiangcheng Financial Holding Group | 11 to 50 | 2021 |
| 3 | Essentia Biosciences | Essentia Biosciences develops cell therapies, gene technology drugs, and medical devices. | Biotech | Haidian | Seed | $14.3M | 2026-01-01 | $14.3M | BioVenture, Haitang Fund, Beijing Molecular Technology | 1 to 10 | 2021 |
| 4 | Magicpen Bio | Magicpen Bio produces and sells crop seeds and conducts agricultural research. | Biotech | Hefei | Seed | $1.4M | 2026-02-06 | $1.4M | Plum Ventures | 2023 | |
| 5 | Tushen Zhihe | Tushen Zhihe provides artificial intelligence protein design services. | Artificial intelligence | Minhang | Seed | $1.4M | 2026-11-09 | $1.5M | Wuxi Capital, CHENGMEI VENTURES | 11 to 50 | 2023 |
| 6 | Levinthal | Levinthal uses artificial intelligence for protein design and co-evolution in food safety and medical care. | Artificial intelligence | Hangzhou | Seed | $1K | 2025-12-09 | $1.6M | ZhenFund, Kaitai Capital, Pan-Lin Capital +1 | 1 to 10 | 2021 |
Table 2. Biotech startups that raised a seed round in China: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Kaitai Capital | Venture capital firm | Hangzhou, China | 3 | 1% | 1 | Levinthal |
| 2 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 2 | 0% | 1 | Zhonghe Gene |
| 3 | Haitang Fund | Venture capital firm | Nankai, China | 2 | 0% | 2 | Zhonghe Gene, Essentia Biosciences |
| 4 | Pan-Lin Capital | Venture capital firm | Shanghai, China | 2 | 0% | 1 | Levinthal |
| 5 | Puhua Capital | Venture capital firm | Hangzhou, China | 2 | 0% | ||
| 6 | MiraclePlus | Startup accelerator | Haidian, China | 2 | 0% | ||
| 7 | Linear Capital | Venture capital firm | Shanghai, China | 2 | 0% | ||
| 8 | Delian Capital | Venture capital firm | Beijing, China | 2 | 0% | ||
| 9 | Thunderstorm VC | Venture capital firm | Guangzhou, China | 2 | 0% | ||
| 10 | Wuxi Capital | Angel group | Wuxi Shi, China | 1 | 0% | 1 | Tushen Zhihe |
| 11 | CHENGMEI VENTURES | Venture capital firm | Beijing, China | 1 | 0% | 1 | Tushen Zhihe |
| 12 | Apricot Capital | Venture capital firm | Shanghai, China | 1 | 0% | 1 | Zhonghe Gene |
| 13 | China Merchants Venture | Venture capital firm | Shenzhen, China | 1 | 0% | 1 | KansenBio |
| 14 | CAS Star | Startup incubator | Xian, China | 1 | 0% | 1 | KansenBio |
| 15 | TusStar | Startup accelerator | Beijing, China | 1 | 0% | 1 | KansenBio |
Table 3. Biotech startups that raised a seed round in China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 336 | 80% | $1.5B |
| Software | 33 | 8% | $116.7M |
| Artificial intelligence | 26 | 6% | $116.1M |
| Hardware | 11 | 3% | $447K |
| Energy | 4 | 1% | $7.4M |
| Commerce | 2 | 0% | |
| Education | 2 | 0% | $2.9M |
Table 4. Biotech startups that raised a seed round in China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 419 | 100% | $1.4M |
Table 5. Biotech startups that raised a seed round in China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups that raised a seed round in China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 3 | 4% | $70.8M |
| October 2026 | 6 | 7% | $44.9M |
| September 2026 | 6 | 7% | $31.4M |
| August 2026 | 7 | 8% | $74.3M |
| July 2026 | 10 | 12% | $9.5M |
| June 2026 | 6 | 7% | $7.4M |
| May 2026 | 7 | 8% | $1.5M |
| April 2026 | 4 | 5% | |
| March 2026 | 9 | 11% | $88.8M |
| February 2026 | 5 | 6% | $41.4M |
| January 2026 | 10 | 12% | $31.5M |
| December 2025 | 9 | 11% | $10.0M |
| November 2025 | 2 | 2% | $60.0M |
Table 7. Biotech startups that raised a seed round in China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 73 | 17% | $401.4M |
| 2025 | 63 | 15% | $252.0M |
| 2024 | 61 | 15% | $187.5M |
| 2023 | 61 | 15% | $114.2M |
| 2022 | 38 | 9% | $219.7M |
| 2021 | 24 | 6% | $64.5M |
Table 8. Biotech startups that raised a seed round in China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 98 | 24% |
| 2020 to 2022 | 134 | 33% |
| 2015 to 2019 | 107 | 26% |
| 2010 to 2014 | 41 | 10% |
| Before 2010 | 27 | 7% |
Table 9. Biotech startups that raised a seed round in China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 27 | 10% |
| 11 to 50 | 147 | 57% |
| 51 to 100 | 51 | 20% |
| 101 to 250 | 20 | 8% |
| 251 to 500 | 8 | 3% |
| 501 to 1,000 | 3 | 1% |
| 1,001 to 5,000 | 2 | 1% |
Table 10. Biotech startups that raised a seed round in China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in China. On 16 November 2026 that is 419 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 14 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 419 rows: 216 have no round amount, 0 no city and 241 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in China whose last round is a seed round are on the list?
- 419, in the file dated 16 November 2026. 84 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 419 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.